Developing therapies for bleeding disorders in need of new treatment options
Millions of people worldwide suffer from serious bleeding disorders. At Hemab, we are developing targeted therapies that reimagine the treatment of blood coagulation disorders to sustain life and human resilience. We are guided by our philosophy that “All Patients Matter” and by the conviction that individuals living with serious bleeding disorders should not have to live with inadequate treatment options.
Our recent progress
Our Therapeutic Focus
While the last decade brought breakthroughs for
some bleeding disorders, people with conditions
that lack available prophylactic therapies have
continued waiting for innovation. These patients
have normalized living with unpredictable bleeds,
limiting their activities and independence. At
Hemab, we believe a different future is
possible—one where prevention, not just
management, becomes the standard of care.
